T. Mizumura et al., INFARCT SIZE-REDUCING EFFECT OF NICORANDIL IS MEDIATED BY THE K-ATP CHANNEL BUT NOT BY ITS NITRATE-LIKE PROPERTIES IN DOGS, Cardiovascular Research, 32(2), 1996, pp. 274-285
Objective: We wished to determine whether the cardioprotective effect
of nicorandil to reduce infarct size is blocked by glibenolamide, a se
lective K-ATP channel antagonist, or methylene blue, a nitric oxide (N
O)/guanylate cyclase inhibitor, in dogs. The second aim was to determi
ne if glyceryl trinitrate produces a cardioprotective effect in the sa
me model and to test if this effect is blocked by methylene blue and n
ot by glibenclamide. We also determined whether adenosine release from
the ischemic-reperfused area is an accurate index of ischemic severit
y in the presence of these drugs Methods: Barbiturate-anesthetized dog
s were subjected to 60 min of left anterior descending coronary artery
(LAD) occlusion followed by 3 h of reperfusion. In the first three gr
oups, either nicorandil (100 mu g/kg bolus + 10 mu g/kg/min), glyceryl
trinitrate (10 mu g/kg bolus + 1 mu g/kg/min) or an equivalent volume
of saline was given intravenously 15 min before LAD occlusion and con
tinued to the time of reperfusion. In the next three groups, glibencla
mide (0.3 mg/kg) was administered 15 min before drug infusion. In the
final three groups, methylene blur (80 mu M) was given intracoronarily
5 min before nicorandil or glyceryl trinitrate and continued until 15
min following reperfusion. Coronary venous blood sample were collecte
d at various times during Ischemia and following reperfusion and the c
oncentration of adenosine measured. Results: Nicorandil produced a mar
ked reduction in infarct size expressed as a percent of the area at ri
sk (NC group, 12.2 +/- 3.2% vs. Control group, 25.7 +/- 4.1%, P < 0.05
) and this effect was completely abolished by pretreatment with gliben
clamide. However, intracoronary administration of methylene blue did n
ot block the cardioprotective effect of nicorandil, On the other hand,
glyceryl trinitrate also produced a significant reduction in infarct
size (GTN group. 13.0 +/- 3.1%) and this effect was reversed by methyl
ene blue but not by glibenclamide. Adenosine concentrations in coronar
y venous blood were significantly reduced after reperfusion in the gro
ups with small infarctions as compared with the Control group. Conclus
ions: These results suggest that sit equieffective cardioprotective do
ses the infarct size-reducing effect of nicorandil in dogs is mediated
via opening oi myocardial K-ATP channels and that the cardioprotectiv
e effect of glyceryl trinitrate is most likely to be mediated via acti
vation of guanylate cyclase at a site yet to be determined.